VIRX

Viracta Therapeutics, Inc. Common Stock
VIRX

Overview Fund Activity
Delisted

VIRX was delisted on the 3rd of February, 2025.

Back to rankings

55 hedge funds and large institutions have $40.4M invested in Viracta Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
-4
Holders Change %
-6.78%
% of All Funds
1.44%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
4
Increased
19
Reduced
13
Closed
8
Calls
$654K
Puts
$175K
Net Calls
+$479K
Net Calls Change
-$302K

Top Buyers

1
GPP
1
Great Point Partners
Connecticut
$7.4M
2
BI
2
BVF Inc
California
$4.29M
3
NMC
3
NEA Management Company
Maryland
$7.01M
4
BBA
4
Baker Bros. Advisors
New York
$3.99M
5
DCM
5
Driehaus Capital Management
Illinois
$1.86M

Top Sellers

1
FCM
1
Farallon Capital Management
California
$0
2
PA
2
Perceptive Advisors
New York
$0
3
QSS
3
Quantitative Systematic Strategies
Florida
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$105K
5
GTC
5
Ghost Tree Capital
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FCM
51
Farallon Capital Management
California
– -$2.49M -14,645 Closed
PA
52
Perceptive Advisors
New York
– -$567K -3,333 Closed
QSS
53
Quantitative Systematic Strategies
Florida
– -$305K -1,588 Closed
GTC
54
Ghost Tree Capital
New York
– -$237K -1,395 Closed
ECM
55
Endurant Capital Management
California
– -$156K -919 Closed
Millennium Management
56
Millennium Management
New York
– -$96K -564 Closed
MA
57
MUFG Americas
New York
– -$3K -17 Closed
1 2
3